Sir,
Relapsing polychondritis (RPC) is an immunemediated condition associated with inflammation of the cartilaginous structures and other tissues throughout the body, particularly the ears, nose, eyes, joints, and respiratory tract. Approximately one-third of RPC cases are observed in association with other diseases, such as systemic vasculitis, connective tissue disorders, or myelodysplastic syndromes.
We report the case of a 73-year-old man with antiphospholipid syndrome (APS) associated with relapsing polychondritis.
He was referred to us with a history of ultrasound-proven, recurrent thrombophlebitis (two episodes involving the popliteal veins, one involving the cephalic vein since 2009).
Coagulation screening was performed and the lupus anticoagulant (LA; including dilute Russell's viper venom time, partial thromboplastin time-LA, and silica clotting time) result was positive. Testing was then repeated 16 weeks later and was once again positive. We searched for anticardiolipin antibodies and anti-ß2-glycoprotein I antibody twice, once at admission and again 16 weeks later, and the result of both was negative. Testing to confirm LA positivity was performed 1 week after discontinuing vitamin K antagonists, when the international normalized ratio (INR) had dropped to below 1.5. Bridging therapy to low-molecularweight heparin was carried out after vitamin K antagonist.
Thus, a diagnosis of antiphospholipid syndrome was made according to Miyakis et al., 1 and longterm anticoagulation therapy was started.
During follow up, the patient presented with persistent fever (up to 38.5 C), bilateral external ear inflammation, nasal involvement with crusting and cartilage flogosis and diffuse polyarthralgia.
During the same time period, he was taken to the emergency room with ocular inflammation and he was discharged with a diagnosis of scleritis/episcleritis that was successfully treated with steroids. His laboratory findings revealed elevated erythrocyte sedimentation rate (up to 100 mm/h) and high Creactive protein levels (12.1 mg/dl). ANA, ENA and ANCA were negative. Blood tests revealed normocytic and normochromic anaemia (Hb 10.2 g/dl), which is consistent with anaemia occurring in chronic diseases. Considering the patient's age and the on-going anticoagulation therapy, we decided to postpone bone marrow biopsy to rule out myelodysplastic syndromes, and haematologic follow up was planned.
Owing to the presence of bilateral auricular chondritis, non-erosive, seronegative inflammatory polyarthritis, nasal chondritis and ocular inflammation (scleritis/episcleritis), a diagnosis of RPC was made on the basis of McAdam et al.'s criteria. 2 Positive histology of the involved cartilage was not required since the clinical setting itself was diagnostic for RPC. 3 Therapy with 10 mg/day prednisone was started, which resulted in an immediate improvement of the auricular lesions and a rapid decrease of the sign/symptoms of inflammation. During 15 months of follow up the patient was placed on a maintenance dose of 5 mg/day prednisone, and there were no relapses.
Some studies have speculated on the possible association between antiphospholipid antibodies and RPC. However, no convincing evidence regarding the possible association between RPC and APS has been found. 3 When APS occurs in RPC it seems to be more closely related to associated conditions such as systemic lupus erythematosus. 4 In our case, no signs or symptoms (except arthralgia) were suggestive of lupus-like conditions, and RPC occurred in a pre-existing condition of primary APS.
To date, the co-existence of APS and RPC has not been convincingly reported in the literature. The present case supports the possible association between these two rare conditions.
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